Belantamab Mafodotin

ATC L01FX15 · 8 markets · 17 records

Belantamab Mafodotin 8 markets · 17 records Forms

GB 3 records · 2 strengths

100 mginjectionBlenrep 100mg powder for concentrate for solution for infusion vials also in AU·ES
70 mginjectionBlenrep 100mg powder for concentrate for solution for infusion vials also in AU·ES

AU 3 records · 3 strengths

100 mginjectionBLENREP belantamab mafodotin 100 mg powder for injection vial also in GB·ES unknown
70 mginjectionBLENREP belantamab mafodotin 100 mg powder for injection vial also in GB·ES unknown

Records without a stated strength · 1 Blenrep

CA 2 records · 2 strengths

100 mgpowderBlenrep
70 mgpowderBlenrep

ES 2 records · 2 strengths

100 mginjectionBlenrep also in GB·AU
70 mginjectionBlenrep also in GB·AU

HK 2 records · 1 strengths

Records without a stated strength · 1 BLENREP Powder for Concentrate for Solution for Infusion

EU 2 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Blenrep

US 1 records · 1 strengths

50 mginjectionBlenrep

TW 1 records · 1 strengths

Records without a stated strength · 1 BLENREP Powder for Concentrate for Solution for Infusion、倍力銳凍晶注射劑

Side-by-side table

Strength / form / release	US	GB	CA	AU	ES	TW	HK	EU
100 mg injection	not recorded	Blenrep 100mg powder for concentrate for solution for infusion vials	not recorded	BLENREP belantamab mafodotin 100 mg powder for injection vial	Blenrep	not recorded	not recorded	not recorded
70 mg injection	not recorded	Blenrep 100mg powder for concentrate for solution for infusion vials	not recorded	BLENREP belantamab mafodotin 100 mg powder for injection vial	Blenrep	not recorded	not recorded	not recorded
50 mg injection	Blenrep	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
100 mg powder	not recorded	not recorded	Blenrep	not recorded	not recorded	not recorded	not recorded	not recorded
70 mg powder	not recorded	not recorded	Blenrep	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Blenrep	not recorded	not recorded	BLENREP Powder for Concentrate for Solution for Infusion	Blenrep
not disclosed injection	not recorded	not recorded	not recorded	not recorded	not recorded	BLENREP Powder for Concentrate for Solution for Infusion 倍力銳凍晶注射劑	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in TW and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en TW que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 TW 有记录（未在本表显示）。另有 1 個規格/劑型僅在 TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.